| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANGO | Common Stock | Options Exercise | $201,240 | +12,000 | +26% | $16.77 | 58,244 | 15 Oct 2021 | Direct | |
| transaction | ANGO | Common Stock | Sale | $335,040 | -12,000 | -21% | $27.92 | 46,244 | 15 Oct 2021 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANGO | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -12,000 | -100% | $0.000000* | 0 | 15 Oct 2021 | Common Stock | 12,000 | $16.77 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.85 to $27.99, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1. |
| F2 | Options for one-fourth of the shares became exercisable on 10/24/2015, 10/24/2016, 10/24/2017 and 10/24/2018, respectively. |